Solventum Corporation (SOLV) has a market capitalization of $11.97B and trades at $69.02. The 52-week range is 60.7-88.2.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 7.7, Earnings Per Share (EPS) of $8.94, annual revenue of $8.33B.
The stock has a beta of 0.77, operates in the Healthcare sector.
